PAT
A Roadmap from Batch to Continuous Manufacturing
January 22 by Pharmaceuticals & Biotechnology EditorContinuous manufacturing is continuing to gain momentum in pharmaceutical and biotech industries, with a demand for greater quality assurance and product consistency. Driven by the potential to incr...
Developing Healthcare Apps in 2015: Market Insights
December 08 by Pharmaceuticals & Biotechnology EditorHealthcare apps will revolutionise healthcare diagnosis, research and provision in this decade and the promise they hold is only beginning to be unlocked. To help you get a snapshot of this exciting...
Facing Cross-Industry Challenges in the Food and Pharma Industries
March 06 by Pharmaceuticals & Biotechnology EditorFood companies are becoming pharma companies. Pharma-foods, the intersection between food and pharmaceuticals, represents an area of growing opportunities for the food sector. Peter J. Boogaard exam...
Gawayne Mahboubian-Jones on International Standards to Support the Application of Process Analytical Technology
January 13 by Andrea CharlesIn this interview Gawayne Mahboubian-Jones, Manager of Quality by Design for Philip Morris International, shares his views on international standards to support the application of Process Analytical...
Process Analytical Technology & Quality by Design Overview 2014
December 14 by Pharmaceuticals & Biotechnology EditorFor the past 11 years, Pharma IQ’s PAT & Quality By Design conference has been bringing you the latest case studies to help show you the benefits of PAT and QbD and how to effectively implement Qb...
3 Key Trends in PAT / QbD Implementation
April 11 by Peter BoogaardPeter Boogaard, Founder of Industrial Lab Automation and Director at Vialis AG recently gave a workshop at the recent 10th anniversary Pat & Quality by Design Conference which recently took plac...
QbD:Regulatory and Scientific Possibilities and Challenges
February 22 by Niamh MadiganGert Ragnarsson, Director of the Swedish Medical Projects Agency, discusses the biggest milestones in QbD over the last decade, including: The establishment of harmonised guidelines Th...
Changes in PAT and QbD Investment and Implementation: 2010-2012
January 08 by Pharmaceuticals & Biotechnology EditorWith budgets being cut and margins becoming tighter, PAT and Quality by Design are becoming more and more critical for the pharmaceutical industry. In a recent survey carried out by Pharma...
The 7 Deadly Sins of Quality Assurance and Quality Control
November 11 by Pharmaceuticals & Biotechnology EditorThe Seven Sins of QA and QC are those transgressions which are detrimental to quality and profitability. You will probably commit some of them every day. We asked the global pharmaceutical commu...
Making a Business Case for PAT and QbD Implementation
October 31 by Andrea CharlesWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! In this presentation Brett Cooper Research...
Best Practice Ways to Overcome Common Challenges in PAT
January 31 by Helen WinsorWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook...
65.2% of Pharma Professionals Need Clarity on PAT and QbD Regulation Submissions
January 18 by Andrea CharlesWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook...